We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA hit online pharmacy Unitedpharmacies.md with a warning letter for marketing on its website unapproved and misbranded products as COVID-19 treatments. Read More
The FDA cited sterile drugmaker Nanobots Healthcare in Houston, Texas in a lengthy Form 483 for deficiencies with testing, sterility, certification and equipment calibration. Read More
The FDA hit Pennsauken, New Jersey drugmaker Cetylite Industries with a Form 483 for multiple GMP failures and the lack of annual product reviews. Read More
The FDA hit a Farmingdale, New York generic drugmaker with a Form 483 for a large number of violations, including inadequate complaint investigations and multiple issues with testing. Read More